AI-Driven Discovery of Brain-Penetrant Galectin-3 Inhibitors for Alzheimer’s Disease Therapy.
AI identifies FJMU1887, a Gal-3 inhibitor, enhancing cognition and reducing neuroinflammation in Alzheimer’s models. 🧠💊
June 23, 2025
Follow us
latest articles
Discover the newest research about AI innovations in 🧠 Neuroscience.
Applications of artificial intelligence in drug discovery for neurological diseases.
AI revolutionizes drug discovery for neurological diseases, enhancing molecule identification and treatment potential. 🤖💊
June 19, 2025
Knowledge Graph-Enhanced Deep Learning Model (H-SYSTEM) for Hypertensive Intracerebral Hemorrhage: Model Development and Validation.
AI-Driven H-SYSTEM Achieves 94.87% Accuracy in Hypertensive Intracerebral Hemorrhage Diagnosis 🧠📊
June 13, 2025
Economic implications of artificial intelligence-driven recommended systems in healthcare: a focus on neurological disorders.
AI in healthcare boosts efficiency, especially for neurological disorders. New models enhance cost-effectiveness and access. 📈🧠
June 5, 2025
Enhanced Early Brain Tumor Detection Crossing Blood-Brain Barrier through MRI Images Using Berkeley Wavelet-Transformation-Based Segmentation.
Enhanced brain tumor detection via MRI using Berkeley wavelet transformation shows improved accuracy and efficiency. 🧠📊
June 4, 2025
Amphetamine use and Parkinson’s disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses.
Amphetamine may lower Parkinson’s disease risk by 41% over 6 years, according to recent AI-driven research. 🧠💊
May 21, 2025
Chipiron Secures $17 Million for Portable MRI Development
Chipiron raises $17 million for portable MRI development, aiming to enhance accessibility in local care centers and clinics. 🏥💰
May 8, 2025
AI and Machine Learning Enhance Stroke Treatment to Minimize Disability
AI and machine learning are improving stroke treatment, aiming to reduce disability and enhance patient outcomes. 🧠💡
May 2, 2025
New AI Tool Assesses Treatment Efficacy for Multiple Sclerosis
New AI tool, MindGlide, assesses treatment effectiveness for multiple sclerosis using MRI scans. Promising advancements in patient care. 🧠💡
April 29, 2025
AI-assisted identification of disability patterns within identical EDSS grades.
AI reveals distinct disability patterns in MS with identical EDSS scores, enhancing clinical assessments. 🤖📊
April 18, 2025